
C Pax 250mg/125mg Injection
Marketer
Ginpax Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview C Pax 250mg/125mg Injection
C-Pax 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation, thus curbing infection spread. Administration must be solely under a doctor's guidance; consistent adherence to the prescribed dosage is crucial. Premature cessation can compromise its effectiveness, requiring completion of the entire treatment regimen. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) demand prompt medical consultation. Complete disclosure of all current medications, including over-the-counter drugs, is essential prior to commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness necessitates abstaining from driving. Adequate rest, proper nutrition, and sufficient hydration contribute significantly to faster recovery. Monitoring treatment efficacy may involve periodic laboratory and diagnostic testing as directed by your physician.
Uses of C Pax 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of C Pax 250mg/125mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of C Pax 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use C Pax 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How C Pax 250mg/125mg Injection works:
Ceftriaxone and Sulbactam 250mg/125mg Injection (C Pax) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and C Pax 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of C Pax, 250mg/125mg, is typically regarded as safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
The administration of C Pax 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of C Pax 250mg/125mg Injection can induce drowsiness, blurred vision, or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of C Pax 250mg/125mg Injection in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering C Pax 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for C Pax 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take C Pax 250mg/125mg Injection :
Should you forget a scheduled dose of C Pax 250mg/125mg Injection, seek advice from your physician.
Facts to Know About C Pax 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
